These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22690083)

  • 1. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
    Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
    World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
    Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
    Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma.
    Shikauchi Y; Saiura A; Kubo T; Niwa Y; Yamamoto J; Murase Y; Yoshikawa H
    Mol Cell Biol; 2009 Apr; 29(7):1944-58. PubMed ID: 19139273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
    Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
    PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
    Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
    Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
    Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of
    Misawa K; Mochizuki D; Imai A; Misawa Y; Endo S; Mima M; Kawasaki H; Carey TE; Kanazawa T
    Clin Epigenetics; 2017; 9():64. PubMed ID: 28616099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation.
    Acun T; Oztas E; Yagci T; Yakicier MC
    BMC Cancer; 2011 Jun; 11():223. PubMed ID: 21645397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
    Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
    World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array.
    Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH
    J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between Methylation of SALL3 and Cervical Cancer].
    Zhao J; Wei X; Yang T; Zhao MY; Pei ML; Yang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):609-614. PubMed ID: 31699190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The methylation of ZHX2 gene promoter enhances AFP gene expression in hepatocellular carcinoma].
    Lv Z; DU Y; Wen J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):706-9. PubMed ID: 23837980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
    Li J; Gong P; Lyu X; Yao K; Li X; Peng H
    Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aza-2'-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines.
    Suh SI; Pyun HY; Cho JW; Baek WK; Park JB; Kwon T; Park JW; Suh MH; Carson DA
    Cancer Lett; 2000 Nov; 160(1):81-8. PubMed ID: 11098088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.